Últimas noticias sobre Concentrix (NASDAQ:CNXC) Bolsa

Concentrix

CNX Coal Resources

Concentrix Corp is a technology enabled company specialized in customer engagement and customer management. The company provides end-to-end capabilities, including CX process optimization, technology innovation and design engineering, front- and back-office automation, analytics and business transformation services to clients in five industry verticals. The Company's verticals are technology and consumer electronics, retail, travel and e-commerce, communications and media, banking, financial services and insurance, and healthcare. Geographically, the company operates in Philippines, Unites States, India, Frances and Others. Maximum revenue is from Technology and consumer electronics industry and geographically from Philippines.

Concentrix Corp

Ratings for Concentrix (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CNXC#NASDAQ">CNXC</a>) were provided by 4 analysts in the past three months, showcasing a mix of bullish and bearish perspectives.
In the table below, you'll find a summary of their recent ratings, revealing the shifting sentiments over the past 30 days and comparing them to the previous months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">1</td>
<td align="right">2</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $61.75, along with a high estimate of $80.00 and a low estimate of $54.00. Experiencing a 12.41% decline, the current average is now lower than the previous average price target of $70.50. 
<img src="https://www.benzinga.com/files/images/story/2025/1743105689_0.png" alt="price target chart" />
<h2>Analyzing Analyst Ratings: A Detailed Breakdown</h2>
In examining recent analyst actions, we gain insights into how financial experts perceive Concentrix. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Vincent Colicchio</td>
<td>Barrington Research</td>
<td>Maintains</td>
<td>Outperform</td>
<td>$54.00</td>
<td>$54.00</td>
</tr>
<tr>
<td>Ruplu Bhattacharya</td>
<td>B of A Securities</td>
<td>Raises</td>
<td>Neutral</td>
<td>$59.00</td>
<td>$58.00</td>
</tr>
<tr>
<td>Vincent Colicchio</td>
<td>Barrington Research</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$54.00</td>
<td>$70.00</td>
</tr>
<tr>
<td>Joseph Vafi</td>
<td>Canaccord Genuity</td>
<td>Lowers</td>
<td>Buy</td>
<td>$80.00</td>
<td>$100.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Responding to changing market dynamics and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their response to recent developments related to Concentrix. This offers insight into analysts' perspectives on the current state of the company.</li>
<li>Rating: Offering a comprehensive view, analysts assess stocks qualitatively, spanning from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Concentrix compared to the broader market.</li>
<li>Price Targets: Analysts navigate through adjustments in price targets, providing estimates for Concentrix's future value. Comparing current and prior targets offers insights into analysts' evolving expectations.</li>
</ul>
Navigating through these analyst evaluations alongside other financial indicators can contribute to a holistic understanding of Concentrix's market standing. Stay informed and make data-driven decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/CNXC/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on Concentrix analyst ratings.</a>
<h2>About Concentrix</h2>
Concentrix Corp is a technology enabled company specialized in customer engagement and customer management. The company provides end-to-end capabilities, including CX process optimization, technology innovation and design engineering, front- and back-office automation, analytics and business transformation services to clients in five industry verticals. The Company's verticals are technology and consumer electronics, retail, travel and e-commerce, communications and media, banking, financial services and insurance, and healthcare. Geographically, the company operates in Philippines, Unites States, India, Frances and Others. Maximum revenue is from Technology and consumer electronics industry and geographically from Philippines.
<h3>Concentrix: A Financial Overview</h3>
Market Capitalization: With restricted market capitalization, the company is positioned below industry averages. This reflects a smaller scale relative to peers.
Revenue Growth: Concentrix's remarkable performance in 3 months is evident. As of 30 November, 2024, the company achieved an impressive revenue growth rate of 9.74%. This signifies a substantial increase in the company's top-line earnings. As compared to competitors, the company surpassed expectations with a growth rate higher than the average among peers in the Industrials sector.
Net Margin: Concentrix's net margin excels beyond industry benchmarks, reaching 4.54%. This signifies efficient cost management and strong financial health.
Return on Equity (ROE): Concentrix's ROE stands out, surpassing industry averages. With an impressive ROE of 2.71%, the company demonstrates effective use of equity capital and strong financial performance.
Return on Assets (ROA): Concentrix's ROA is below industry standards, pointing towards difficulties in efficiently utilizing assets. With an ROA of 0.92%, the company may encounter challenges in delivering satisfactory returns from its assets.
Debt Management: Concentrix's debt-to-equity ratio is below the industry average. With a ratio of 1.17, the company relies less on debt financing, maintaining a healthier balance between debt and equity, which can be viewed positively by investors.
<h2>The Significance of Analyst Ratings Explained</h2>
Analysts are specialists within banking and financial systems that typically report for specific stocks or within defined sectors. These people research company financial statements, sit in conference calls and meetings, and speak with relevant insiders to determine what are known as analyst ratings for stocks. Typically, analysts will rate each stock once a quarter. 
Analysts may enhance their evaluations by incorporating forecasts for metrics like growth estimates, earnings, and revenue, delivering additional guidance to investors. It is vital to acknowledge that, although experts in stocks and sectors, analysts are human and express their opinions when providing insights.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Analyst Ratings

CNXC

Analyst Expectations For Concentrix's Future

<h3>Gainers</h3>
<ul>
<li>Greenland Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GTEC#NASDAQ">GTEC</a>) stock moved upwards by 63.4% to $2.14 during Thursday's regular session. The company's market cap stands at $29.0 million. The company's, Q4 earnings came out yesterday. </li>
<li>Concentrix (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CNXC#NASDAQ">CNXC</a>) shares increased by 35.59% to $61.94. The company's market cap stands at $3.9 billion. As per the press release, Q1 earnings came out yesterday. </li>
<li>Baiya International Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BIYA#NASDAQ">BIYA</a>) stock moved upwards by 30.87% to $6.4. The market value of their outstanding shares is at $80.0 million. </li>
<li>Hertz Global Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HTZ#NASDAQ">HTZ</a>) stock moved upwards by 19.27% to $4.12. The company's market cap stands at $1.2 billion. </li>
<li>Avis Budget Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CAR#NASDAQ">CAR</a>) stock rose 18.96% to $73.22. The market value of their outstanding shares is at $2.5 billion. </li>
<li>Satellogic (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SATL#NASDAQ">SATL</a>) stock increased by 13.6% to $4.26. The company's market cap stands at $411.5 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>LanzaTech Global (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LNZA#NASDAQ">LNZA</a>) stock decreased by 25.8% to $0.27 during Thursday's regular session. The market value of their outstanding shares is at $52.4 million. </li>
<li>WANG &amp; LEE Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WLGS#NASDAQ">WLGS</a>) stock decreased by 20.68% to $0.25. The market value of their outstanding shares is at $3.8 million. </li>
<li>3D Sys (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DDD#NYSE">DDD</a>) stock decreased by 18.94% to $2.21. The company's market cap stands at $299.0 million. The company's, Q4 earnings came out yesterday. </li>
<li>Linkers Industries (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LNKS#NASDAQ">LNKS</a>) shares decreased by 15.98% to $0.54. The company's market cap stands at $7.2 million. </li>
<li>HUHUTECH International Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HUHU#NASDAQ">HUHU</a>) shares decreased by 14.83% to $4.31. The company's market cap stands at $91.2 million. </li>
<li>SES AI (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SES#NYSE">SES</a>) shares declined by 10.32% to $0.57. The company's market cap stands at $203.7 million. 
See Also: <a href="http://www.benzinga.com/money/best-industrials-stocks/" title="www.benzinga.com/money/best-industrials-stocks/">www.benzinga.com/money/best-industrials-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Movers

BIYA

GTEC

HUHU

LNKS

LNZA

SATL

WLGS

12 Industrials Stocks Moving In Thursday's Intraday Session

WIIM

Concentrix shares are trading higher following better-than-expected Q1 financial results and Q2 revenue guidance above estimates. Additionally, B of A  Securities raised its price target on the stock from $58 to $59.

Barrington Research analyst Vincent Colicchio maintains Concentrix (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CNXC#NASDAQ">CNXC</a>) with a Outperform and maintains $54 price target.

News

Price Target

Barrington Research Maintains Outperform on Concentrix, Maintains $54 Price Target

U.S. stocks were lower, with the Dow Jones index falling around 0.2% on Thursday.
Shares of Concentrix Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CNXC#NASDAQ">CNXC</a>) rose sharply during Thursday's session after the company reported better-than-expected first-quarter financial results and issued second-quarter revenue guidance <a href="https://in.benzinga.com/news/earnings/25/03/44504468/concentrix-shares-pop-on-strong-q1-results-raised-revenue-guidance">above estimates</a>.
Concentrix reported quarterly earnings of $2.79 per share, which beat the analyst consensus estimate of $2.58. Quarterly revenue came in at $2.37 billion, which beat the analyst consensus estimate of $2.36 billion and is down slightly from revenue of $2.4 billion from the same period last year.
Concentrix raised its fiscal 2025 reported revenue outlook from between $9.47 billion and $9.61 billion to between $9.49 billion and $9.635 billion, versus the $9.54 billion estimate.
Concentrix shares jumped 27% to $58.28 on Thursday.
Here are some other big stocks recording gains in today's session.
<ul>
<li>Soleno Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SLNO#NASDAQ">SLNO</a>) shares jumped 40.3% to $68.72 after the company announced it secured FDA approval for its first commercial drug for a rare genetic disorder.</li>
<li>Petco Health and Wellness Company, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WOOF#NASDAQ">WOOF</a>) gained 32% to $3.2399 following fourth-quarter results.</li>
<li>Hertz Global Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HTZ#NASDAQ">HTZ</a>) rose 23.5% to $4.2650.</li>
<li>Jiayin Group Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JFIN#NASDAQ">JFIN</a>) climbed 20.2% to $14.55 following fourth-quarter results.</li>
<li>Avis Budget Group, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CAR#NASDAQ">CAR</a>) gained 19.7% to $73.72.</li>
<li>MillerKnoll, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MLKN#NASDAQ">MLKN</a>) shares climbed 11.7% to $20.45 after reporting third-quarter results.</li>
<li>Edgewise Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EWTX#NASDAQ">EWTX</a>) rose 11.6% to $24.85.</li>
<li>ImmunityBio, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IBRX#NASDAQ">IBRX</a>) gained 11% to $3.0850.</li>
<li>iQIYI, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IQ#NASDAQ">IQ</a>) shares rose 8% to $2.4150.</li>
<li>Zai Lab Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZLAB#NASDAQ">ZLAB</a>) gained 6.4% to $36.09. Cantor Fitzgerald analyst Li Watsek reiterated Zai Lab with an Overweight rating.</li>
<li>Dollar Tree, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DLTR#NASDAQ">DLTR</a>) rose 5.5% to $73.08. Telsey Advisory Group analyst Joseph Feldman maintained Dollar Tree with a Market Perform and raised the price target from $75 to $82.</li>
<li>Ollie&#8217;s Bargain Outlet Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OLLI#NASDAQ">OLLI</a>) gained 4.7% to $113.24.</li>
</ul>
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/25/03/44492633/jim-cramer-palantir-is-a-winner-recommends-selling-this-tech-stock">Jim Cramer: Palantir Is A &#8216;Winner,&#8217; Recommends Selling This Tech Stock</a></li>
</ul>

Intraday Update

Markets

Trading Ideas

DLTR

EWTX

IBRX

JFIN

MLKN

OLLI

SLNO

WOOF

ZLAB

Concentrix Posts Better-Than-Expected Earnings, Joins Soleno Therapeutics, Petco Health and Wellness, MillerKnoll And Other Big Stocks Moving Higher On Thursday

B of A Securities analyst Ruplu Bhattacharya maintains Concentrix (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CNXC#NASDAQ">CNXC</a>) with a Neutral and raises the price target from $58 to $59.

B of A Securities Maintains Neutral on Concentrix, Raises Price Target to $59

<h3>Gainers</h3>
<ul>
<li>Greenland Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GTEC#NASDAQ">GTEC</a>) stock increased by 65.1% to $2.13 during Wednesday's after-market session. The market value of their outstanding shares is at $28.9 million. As per the news, the Q4 earnings report came out today. </li>
<li>BioNexus Gene Lab (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BGLC#NASDAQ">BGLC</a>) shares rose 43.65% to $0.46. The market value of their outstanding shares is at $8.2 million. </li>
<li>Lakeside Holding (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LSH#NASDAQ">LSH</a>) shares moved upwards by 12.5% to $1.35. The company's market cap stands at $10.1 million. </li>
<li>Urban-gro (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UGRO#NASDAQ">UGRO</a>) shares rose 12.38% to $0.6. The company's market cap stands at $7.6 million. </li>
<li>Concentrix (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CNXC#NASDAQ">CNXC</a>) stock rose 10.66% to $50.55. The market value of their outstanding shares is at $3.2 billion. As per the press release, Q1 earnings came out today. </li>
<li>Steelcase (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SCS#NYSE">SCS</a>) shares moved upwards by 10.0% to $11.66. The market value of their outstanding shares is at $1.3 billion. The company's, Q4 earnings came out today. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>American Rebel Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AREB#NASDAQ">AREB</a>) stock fell 24.3% to $0.1 during Wednesday's after-market session. </li>
<li>Aeries Technology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AERT#NASDAQ">AERT</a>) shares declined by 20.83% to $0.54. The market value of their outstanding shares is at $24.0 million. </li>
<li>ConnectM Technology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CNTM#NASDAQ">CNTM</a>) shares fell 10.36% to $0.56. The market value of their outstanding shares is at $16.2 million. </li>
<li>3D Sys (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DDD#NYSE">DDD</a>) stock decreased by 7.36% to $2.52. The company's market cap stands at $341.7 million. As per the press release, Q4 earnings came out today. </li>
<li>Samfine Creation Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SFHG#NASDAQ">SFHG</a>) stock declined by 6.95% to $0.67. The market value of their outstanding shares is at $14.9 million. </li>
<li>Lichen International (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LICN#NASDAQ">LICN</a>) stock decreased by 5.22% to $4.36. The market value of their outstanding shares is at $2.6 million. 
See Also: <a href="http://www.benzinga.com/money/best-industrials-stocks/" title="www.benzinga.com/money/best-industrials-stocks/">www.benzinga.com/money/best-industrials-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Advanced Environmental Recycling Technologies

AERT

AREB

BGLC

CNTM

LICN

SFHG

UGRO

12 Industrials Stocks Moving In Wednesday's After-Market Session

Concentrix Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CNXC#NASDAQ">CNXC</a>) released its first-quarter results after Wednesday's closing bell. Here's a look at the key figures <a href="https://www.benzinga.com/pressreleases/25/03/g44502934/concentrix-reports-first-quarter-2025-results">from the quarter. </a>
The Details: Concentrix reported quarterly earnings of $2.79 per share, which beat the analyst consensus estimate of $2.58. Quarterly revenue came in at $2.37 billion, which beat the analyst consensus estimate of $2.36 billion and is down slightly from revenue of $2.4 billion from the same period last year.
Read Next: <a href="https://www.benzinga.com/news/global/25/03/44494896/us-adds-50-chinese-entities-to-export-restriction-list-curtailing-access-to-nvidia-amd-chips">US Adds 50 Chinese Entities To Export Restriction List Curtailing Access To Nvidia, AMD Chips</a>
&#8220;Our first quarter results demonstrate our progress as we win quality business and take advantage of GenAI opportunities, leveraging our unique technology and service capabilities to drive our clients&#8217; success,&#8221; said Chris Caldwell, CEO of Concentrix. 
&#8220;With a solid start to the year, we remain on track to deliver ongoing constant currency revenue growth, while expanding margins and growing free cash flow in 2025 and beyond,&#8221; Caldwell added.
Outlook:&nbsp;Concentrix raised its fiscal 2025 reported revenue outlook from between $9.47 billion&nbsp;and $9.61 billion to between&nbsp;$9.49 billion and $9.635 billion, versus the&nbsp;$9.54 billion estimate. The company continues to see fiscal year adjusted EPS of $11.18 to $11.77 per share, versus the $11.44 estimate. 
CNXC Price Action: According to data from <a href="https://pro.benzinga.com/?gspk=YWRhbWVja2VydDUzMzY&amp;gsxid=zBMR4PKmcgBw">Benzinga Pro</a>, Concentrix shares were up 11.15% after-hours at $50.77 Wednesday.  
Read More:
<ul>
<li><a href="https://www.benzinga.com/news/global/25/03/44477467/trumps-tariffs-on-buyers-of-venezuelan-oil-could-boost-energy-sector-exxon-mobil-stock">Trump&#8217;s Tariffs On Buyers Of Venezuelan Oil Could Boost Energy Sector, Exxon Mobil Stock&nbsp;</a></li>
</ul>
Image: Shutterstock

Earnings

After-Hours Center

Tech

Concentrix Shares Pop On Strong Q1 Results, Raised Revenue Guidance

Based on current exchange rates, the expectations assume an approximate 135-basis point negative impact of foreign exchange rates compared with the prior year. The guidance implies constant currency revenue growth for the full year of 0% to 1.5%.
Operating income of $669 million to $709 million and non-GAAP operating income of $1.300 billion to $1.340 billion.
In addition, the Company expects to generate approximately $625 million to $650 million of adjusted free cash flow in fiscal year 2025.

Guidance

Concentrix Raises FY25 Reported Revenue Outlook From $9.47B - $9.61B To $9.49B - $9.635B (Est $9.543B), Continues To See Adj EPS Of $11.18 - $11.77 (Est $11.44)

Concentrix shares are trading higher after the company reported better-than-expected Q1 financial results and issued Q2 revenue guidance above estimates.

Based on current exchange rates, these expectations assume an approximate 90-basis point negative impact of foreign exchange rates compared with the prior year period. The guidance implies constant currency revenue growth for the quarter ranging from 0.50% to 1.25%.
Operating income of $155 million to $165 million and non-GAAP operating income of $315 million to $325 million.
&nbsp;

Concentrix Expects Q2 Reported Revenue Of $2.37B - $2.39B (Est $2.365B), Adj EPS Of $2.69 - $2.80 (Est $2.78)

Concentrix Expects To Return More Than $240M To Shareholders In FY25 Through Share Repurchases And Dividends

Concentrix (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CNXC#NASDAQ">CNXC</a>) reported quarterly earnings of $2.79 per share which beat the analyst consensus estimate of $2.58 by 8.14 percent. This is a 8.56 percent increase over earnings of $2.57 per share from the same period last year. The company reported quarterly sales of $2.37 billion which beat the analyst consensus estimate of $2.36 billion by 0.33 percent. This is a 1.28 percent decrease over sales of $2.40 billion the same period last year.

Earnings Beats

Concentrix Q1 2025 Adj EPS $2.79 Beats $2.58 Estimate, Sales $2.37B Beat $2.36B Estimate

<h3>Companies Reporting Before The Bell</h3>
• Allurion Technologies (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ALUR#NYSE">ALUR</a>) is estimated to report quarterly loss at $5.00 per share on revenue of $5.60 million. 
• Dollar Tree (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DLTR#NASDAQ">DLTR</a>) is projected to report quarterly earnings at $2.18 per share on revenue of $8.23 billion. 
• Chewy (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CHWY#NYSE">CHWY</a>) is projected to report quarterly earnings at $0.05 per share on revenue of $3.20 billion. 
• Titan America (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TTAM#NYSE">TTAM</a>) is expected to report quarterly earnings at $0.21 per share on revenue of $384.72 million. 
• Cintas (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CTAS#NASDAQ">CTAS</a>) is likely to report quarterly earnings at $1.06 per share on revenue of $2.60 billion. 
• SailPoint (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SAIL#NASDAQ">SAIL</a>) is expected to report quarterly loss at $0.03 per share on revenue of $202.71 million. 
• REX American Resources (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/REX#NYSE">REX</a>) is estimated to report quarterly earnings at $0.27 per share on revenue of $152.00 million. 
• CollPlant Biotechnologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CLGN#NASDAQ">CLGN</a>) is estimated to report quarterly earnings at $0.00 per share on revenue of $358 thousand. 
• Target Hospitality (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TH#NASDAQ">TH</a>) is expected to report quarterly earnings at $0.07 per share on revenue of $80.10 million. 
• JinkoSolar Holding Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JKS#NYSE">JKS</a>) is estimated to report quarterly loss at $0.46 per share on revenue of $3.59 billion. 
• BRP (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DOOO#NASDAQ">DOOO</a>) is expected to report quarterly earnings at $0.62 per share on revenue of $1.35 billion. 
• Canaan (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CAN#NASDAQ">CAN</a>) is expected to report quarterly loss at $0.14 per share on revenue of $88.50 million. 
• Precision BioSciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DTIL#NASDAQ">DTIL</a>) is expected to report quarterly loss at $2.94 per share on revenue of $4.28 million. 
• Cheetah Mobile (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CMCM#NYSE">CMCM</a>) is expected to report earnings for its fourth quarter. 
• Paychex (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PAYX#NASDAQ">PAYX</a>) is projected to report quarterly earnings at $1.48 per share on revenue of $1.51 billion. 
• Zhihu (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ZH#NYSE">ZH</a>) is projected to report earnings for its fourth quarter. 
<h3>Companies Reporting After The Bell</h3>
• Snail (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SNAL#NASDAQ">SNAL</a>) is estimated to report earnings for its fourth quarter. 
• Integra Resources (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/ITRG#AMEX">ITRG</a>) is likely to report earnings for its fourth quarter. 
• TAT Techs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TATT#NASDAQ">TATT</a>) is likely to report earnings for its fourth quarter. 
• Envela (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/ELA#AMEX">ELA</a>) is likely to report quarterly earnings at $0.05 per share on revenue of $40.63 million. 
• 3D Sys (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DDD#NYSE">DDD</a>) is projected to report quarterly loss at $0.11 per share on revenue of $114.96 million. 
• BioCardia (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BCDA#NASDAQ">BCDA</a>) is projected to report quarterly loss at $0.87 per share on revenue of $20 thousand. 
• Oxbridge Re Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OXBR#NASDAQ">OXBR</a>) is projected to report earnings for its fourth quarter. 
• Durect (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DRRX#NASDAQ">DRRX</a>) is estimated to report quarterly loss at $0.02 per share on revenue of $6.91 million. 
• Journey Medical (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DERM#NASDAQ">DERM</a>) is estimated to report quarterly loss at $0.15 per share on revenue of $14.21 million. 
• Zepp Health (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ZEPP#NYSE">ZEPP</a>) is expected to report earnings for its fourth quarter. 
• FGI Industries (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FGI#NASDAQ">FGI</a>) is projected to report quarterly loss at $0.03 per share on revenue of $33.09 million. 
• Jefferies Financial Gr (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JEF#NYSE">JEF</a>) is projected to report quarterly earnings at $1.13 per share on revenue of $1.97 billion. 
• Microvision (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MVIS#NASDAQ">MVIS</a>) is estimated to report quarterly loss at $0.08 per share on revenue of $2.10 million. 
• H.B. Fuller (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FUL#NYSE">FUL</a>) is projected to report quarterly earnings at $0.63 per share on revenue of $797.68 million. 
• Dyadic International (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DYAI#NASDAQ">DYAI</a>) is expected to report quarterly loss at $0.06 per share on revenue of $1.35 million. 
• Usio (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/USIO#NASDAQ">USIO</a>) is expected to report quarterly earnings at $0.00 per share on revenue of $21.40 million. 
• Verint Systems (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VRNT#NASDAQ">VRNT</a>) is estimated to report quarterly earnings at $1.27 per share on revenue of $276.82 million. 
• Concentrix (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CNXC#NASDAQ">CNXC</a>) is estimated to report quarterly earnings at $3.01 per share on revenue of $2.47 billion. 
• Spruce Power Holding (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPRU#NYSE">SPRU</a>) is projected to report earnings for its fourth quarter. 
• Steelcase (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SCS#NYSE">SCS</a>) is likely to report quarterly earnings at $0.21 per share on revenue of $790.90 million. 
• Guardian Pharmacy Service (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GRDN#NYSE">GRDN</a>) is projected to report quarterly earnings at $0.20 per share on revenue of $320.52 million. 
• Perspective Therapeutics (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/CATX#AMEX">CATX</a>) is expected to report quarterly loss at $0.26 per share on revenue of $232 thousand. 
• MillerKnoll (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MLKN#NASDAQ">MLKN</a>) is projected to report quarterly earnings at $0.44 per share on revenue of $918.88 million. 
• Alvotech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALVO#NASDAQ">ALVO</a>) is estimated to report quarterly loss at $0.01 per share on revenue of $87.50 million. 
• Inventiva (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IVA#NASDAQ">IVA</a>) is estimated to report earnings for its Fiscal Year 2024. 
• Petco Health and Wellness (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WOOF#NASDAQ">WOOF</a>) is projected to report quarterly earnings at $0.01 per share on revenue of $1.56 billion. 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

ALUR

ALVO

BCDA

CATX

CHWY

CLGN

CMCM

CTAS

DERM

DOOO

DRRX

DTIL

DYAI

GRDN

ITRG

MVIS

OXBR

PAYX

SAIL

SNAL

Spruce Power Holding Corporation Class A Common Stock

SPRU

TATT

TTAM

USIO

VRNT

ZEPP

Earnings Scheduled For March 26, 2025

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our <a href="https://www.benzinga.com/analyst-stock-ratings">analyst ratings page</a>.
<ul>
<li>Chardan Capital slashed Century Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IPSC#NASDAQ">IPSC</a>) price target from $11 to $7. Chardan Capital analyst Geulah Livshits maintained a Buy rating. Century Therapeutics shares closed at $0.5550 on Friday. <a href="https://www.benzinga.com/quote/IPSC/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Piper Sandler cut the price target for Lowe&#8217;s Companies, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LOW#NYSE">LOW</a>) from $296 to $269. Piper Sandler analyst Peter Keith maintained an Overweight rating. Lowe&#8217;s shares closed at $227.07 on Friday. See how other analysts <a href="https://www.benzinga.com/quote/LOW/analyst-ratings">view this stock</a>.</li>
<li>JP Morgan boosted Alnylam Pharmaceuticals, Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALNY#NASDAQ">ALNY</a>) price target from $280 to $328. JP Morgan analyst Jessica Fye upgraded the stock from Neutral to Overweight. Alnylam Pharmaceuticals shares closed at $283.34 on Friday. <a href="https://www.benzinga.com/quote/ALNY/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Jefferies cut the price target for FedEx Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FDX#NYSE">FDX</a>) from $300 to $275. Jefferies analyst Stephanie Moore upgraded the stock from Hold to Buy. FedEx shares closed at $230.33 on Friday. <a href="https://www.benzinga.com/quote/FDX/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Barrington Research lowered the price target for Concentrix Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CNXC#NASDAQ">CNXC</a>) from $70 to $54. Barrington Research analyst Vincent Colicchio maintained an Outperform rating. Concentrix shares closed at $44.93 on Friday. <a href="https://www.benzinga.com/quote/CNXC/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Telsey Advisory Group cut RH (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RH#NYSE">RH</a>) price target from $500 to $420. Telsey Advisory Group analyst Cristina Fernandez maintained an Outperform rating. RH shares settled at $242.18 on Friday. <a href="https://www.benzinga.com/quote/RH/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Evercore ISI Group cut Lennar Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LEN#NYSE">LEN</a>) price target from $159 to $131. Evercore ISI Group analyst Stephen Kim downgraded the stock from Outperform to In-Line. Lennar shares closed at $115.22 on Friday. <a href="https://www.benzinga.com/quote/LEN/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Guggenheim raised Pinterest, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PINS#NYSE">PINS</a>) price target from $39 to $40. Guggenheim analyst Michael Morris upgraded the stock from Neutral to Buy. Pinterest shares closed at $32.42 on Friday.  <a href="https://www.benzinga.com/quote/PINS/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Raymond James cut the price target for Lumentum Holdings Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LITE#NASDAQ">LITE</a>) from $96 to $82. Raymond James analyst Simon Leopold upgraded the stock from Outperform to Strong Buy. Lumentum shares settled at $66.61 on Friday. <a href="https://www.benzinga.com/quote/LITE/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Stifel raised Carnival Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CCL#NYSE">CCL</a>) price target from $30 to $31. Stifel analyst Steven Wieczynski maintained a Buy rating. Carnival shares closed at $20.94 on Friday. <a href="https://www.benzinga.com/quote/CCL/analyst-ratings">See how other analysts view this stock</a>.</li>
</ul>
Read This Next: 
<ul>
<li><a href="https://www.benzinga.com/trading-ideas/long-ideas/25/03/44454777/top-3-risk-off-stocks-that-may-explode-this-month-2">Top 3 Risk Off Stocks That May Explode This Month</a></li>
</ul>

Pre-Market Outlook

ALNY

IPSC

LITE

PINS

Carnival To Rally Around 48%? Here Are 10 Top Analyst Forecasts For Monday

Barrington Research analyst Vincent Colicchio maintains Concentrix (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CNXC#NASDAQ">CNXC</a>) with a Outperform and lowers the price target from $70 to $54.

Barrington Research Maintains Outperform on Concentrix, Lowers Price Target to $54

Mark Cuban extended his support to President Donald Trump&#8216;s new &#8216;Gold Card&#8217; scheme to obtain U.S. citizenship if these cards were sold to corporations who hire immigrants. Billionaire entrepreneur and Dallas Mavericks owner added that the &#8220;H1b Visa game is ridiculous.&#8221;
What Happened: <a href="https://www.benzinga.com/news/25/02/43985233/mark-cuban-calls-deductibles-the-biggest-problem-in-healthcare-system-needs-to-be-redesigned">Cuban</a> proposed a new way for high-skilled workers to obtain U.S. citizenship in his latest X post.
Agreeing with President Trump on generating revenue via handing over citizenships, Cuban added that corporations could pay $5 million for an employee earning over $500,000 per year to get immediate citizenship, provided they pass a thorough background check.
Cuban argues that if a person is highly valuable to a company, the company should be willing to pay for the right to employ them in the U.S. He further suggests that if companies are not going to hire American workers, they should at least contribute to the tax base for the privilege of hiring foreign talent.
The billionaire investor also believes the current H-1B visa system, which uses a lottery and has caps, is &#8220;broken.&#8221;
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">I ACTUALLY LIKE THIS IDEA IF WE SELL THEM TO CORPORATIONS. The H1b Visa game is ridiculous. Go to companies and tell them, $5m for any employee making over 500k, and they get immediate citizenship if they pass an advanced background check. Without citizenship , and only 3… <a href="https://t.co/O0xlSUVrBW">https://t.co/O0xlSUVrBW</a>
&mdash; Mark Cuban (@mcuban) <a href="https://twitter.com/mcuban/status/1896398624482841050?ref_src=twsrc%5Etfw">March 3, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
This comes after Trump addressed the amount of revenue that could be generated via selling &#8216;Gold Cards&#8217; during a press conference. He said, &#8220;If we sell a million &#8211; that&#8217;s $5 trillion… if we sell 10 million, that&#8217;s $50 trillion. That means our debt is totally paid off, and we have $15 trillion above that.&#8221;
See Also: <a href="https://www.benzinga.com/news/earnings/25/02/44038874/nvidia-wipes-375-billion-of-investor-wealth-in-2025-margin-of-error-razor-thin-says-analyst-reiterating-buy-on-dips-call">Nvidia Wipes $375 Billion Of Investor Wealth In 2025: &#8216;Margin Of Error Razor Thin,&#8217; Says Analyst Reiterating &#8216;Buy On Dips&#8217; Call</a>
Why It Matters: As the President and corporate tycoons agree to generate revenue via this route, a 2024 report by the American Immigration Council highlighted that immigrant entrepreneurs make up 22.6% of all entrepreneurs nationwide.
According to the study, from the New American companies that made the 2024 Fortune 500 list, 46%, or 230 companies, were founded by immigrants or their children and each company employs about 67,332 workers.
Here are the names of a few listed entities that are new entrants in the Fortune 500 list, hiring and led by immigrants.
<figure class="wp-block-table is-style-stripes"> 
<table>
<tbody>
<tr>
<td>Stocks</td>
<td>YTD Performance</td>
<td>One Year Performance</td>
</tr>
<tr>
<td>GE HealthCare Technologies Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GEHC#NASDAQ">GEHC</a>)</td>
<td>11.44%</td>
<td>-5.80%</td>
</tr>
<tr>
<td>EchoStar Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SATS#NASDAQ">SATS</a>)</td>
<td>37.27%</td>
<td>139.31%</td>
</tr>
<tr>
<td>DoorDash Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DASH#NASDAQ">DASH</a>)</td>
<td>16.28%</td>
<td>49.88%</td>
</tr>
<tr>
<td>Microchip Technology Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MCHP#NASDAQ">MCHP</a>)</td>
<td>3.48%</td>
<td>-32.28%</td>
</tr>
<tr>
<td>Prologis Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PLD#NYSE">PLD</a>)</td>
<td>18.86%</td>
<td>-7.25%</td>
</tr>
<tr>
<td>Interactive Brokers Group, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IBKR#NASDAQ">IBKR</a>)</td>
<td>12%</td>
<td>84.04%</td>
</tr>
<tr>
<td>Xylem Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XYL#NYSE">XYL</a>)</td>
<td>12.88%</td>
<td>2.38%</td>
</tr>
<tr>
<td>Monster Beverage Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MNST#NASDAQ">MNST</a>)</td>
<td>4.47%</td>
<td>-6.58%</td>
</tr>
<tr>
<td>Super Micro Computer Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SMCI#NASDAQ">SMCI</a>)</td>
<td>37.97%</td>
<td>-61.41%</td>
</tr>
<tr>
<td>Concentrix Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CNXC#NASDAQ">CNXC</a>)</td>
<td>3.72%</td>
<td>-36.66%</td>
</tr>
</tbody>
</table>
</figure>
Apart from these, the &#8216;Magnificent 7,&#8217; &#8216;Big Tech&#8217; and other U.S. giants also hire many immigrants and they can boost the U.S. government revenue by purchasing &#8216;Gold Cards&#8217; for their talented and deserving employees as suggested by Mark Cuban.
Price Action: The SPDR S&amp;P 500 ETF Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>) and Invesco QQQ Trust ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QQQ#NASDAQ">QQQ</a>), which track the S&amp;P 500 index and Nasdaq 100 index, respectively, rose on Friday. The SPY was up 1.56% to $594.18, and the QQQ also advanced 1.56% to $508.10, according to <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a> data.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/25/02/44034837/soundhound-ais-polaris-outperforms-google-and-openai-forays-in-energy-sector-with-seven-figure-deal-amid-q4-beat">SoundHound AI Says Polaris Speech Recognition Model Outperforms Google, OpenAI: Company Forays Into Energy Sector With 7-Figure Deal</a></li>
</ul>
Photo courtesy: Shutterstock

Equities

Government

Politics

DASH

GEHC

IBKR

MCHP

MNST

SATS

SMCI

Mark Cuban Supports Trump's New 'Gold Card' Scheme If Sold To Corporations For Employee Citizenship: Here're The Listed-Companies With Most Number Of Immigrants

In the current market session, Concentrix Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CNXC#NASDAQ">CNXC</a>) share price is at $50.11, after a 4.15% drop. Over the past month, the stock spiked by 8.20%, but over the past year, it actually decreased by 42.54%. With good short-term performance like this, and questionable long-term performance, long-term shareholders might want to start looking into the company's price-to-earnings ratio.

<img src="https://www.benzinga.com/files/images/story/2025/1738615511_0.png" alt="Past Year Chart" />

<h3>How Does Concentrix P/E Compare to Other Companies?</h3>
The P/E ratio measures the current share price to the company's EPS. It is used by long-term investors to analyze the company's current performance against it's past earnings, historical data and aggregate market data for the industry or the indices, such as S&amp;P 500. A higher P/E indicates that investors expect the company to perform better in the future, and the stock is probably overvalued, but not necessarily. It also could indicate that investors are willing to pay a higher share price currently, because they expect the company to perform better in the upcoming quarters. This leads investors to also remain optimistic about rising dividends in the future. 
Compared to the aggregate P/E ratio of the 25.05 in the Professional Services industry, Concentrix Inc. has a lower P/E ratio of 14.09. Shareholders might be inclined to think that the stock might perform worse than it's industry peers. It's also possible that the stock is undervalued. 

<img src="https://www.benzinga.com/files/images/story/2025/1738615511_1.png" alt="Guage" />

In summary, while the price-to-earnings ratio is a valuable tool for investors to evaluate a company's market performance, it should be used with caution. A low P/E ratio can be an indication of undervaluation, but it can also suggest weak growth prospects or financial instability. Moreover, the P/E ratio is just one of many metrics that investors should consider when making investment decisions, and it should be evaluated alongside other financial ratios, industry trends, and qualitative factors. By taking a comprehensive approach to analyzing a company's financial health, investors can make well-informed decisions that are more likely to lead to successful outcomes.

P/E Ratio Insights for Concentrix

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our <a href="https://www.benzinga.com/analyst-stock-ratings">analyst ratings page</a>.
<ul>
<li>JP Morgan cut the price target for The Procter &amp; Gamble Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PG#NYSE">PG</a>) from $186 to $181. JP Morgan analyst Andrea Teixeira maintained an Overweight rating. Procter &amp; Gamble shares closed at $159.65 on Wednesday. <a href="https://www.benzinga.com/quote/PG/analyst-ratings">See how other analysts view this stock.</a></li>
</ul>
<ul>
<li>Canaccord Genuity slashed Concentrix Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CNXC#NYSE">CNXC</a>) price target from $100 to $80. Canaccord Genuity analyst Joseph Vafi maintained a Buy rating. Concentrix shares closed at $47.47 on Wednesday. <a href="https://www.benzinga.com/quote/CNXC/analyst-ratings">See how other analysts view this stock.</a></li>
<li>JP Morgan cut the price target for The Hershey Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HSY#NYSE">HSY</a>) from $171 to $151. JP Morgan analyst Ken Goldman maintained a Neutral rating. Hershey shares closed at $155.31 on Wednesday. <a href="https://www.benzinga.com/quote/HSY/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Truist Securities increased the price target for Cracker Barrel Old Country Store, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CBRL#NASDAQ">CBRL</a>) from $48 to $51. Truist Securities analyst Jake Bartlett maintained a Hold rating. Cracker Barrel shares closed at $57.57 on Wednesday. <a href="https://www.benzinga.com/quote/CBRL/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Baird raised DexCom, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DXCM#NASDAQ">DXCM</a>) price target from $86 to $104. Baird analyst Jeff Johnson upgraded the stock from Neutral to Outperform. DexCom shares settled at $80.40 on Wednesday. <a href="https://www.benzinga.com/quote/DXCM/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Deutsche Bank raised The Bank of New York Mellon Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BK#NYSE">BK</a>) price target from $94 to $98. Deutsche Bank analyst Brian Bedell maintained a Buy rating. Bank of New York Mellon shares closed at $82.04 on Wednesday. <a href="https://www.benzinga.com/quote/BK/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Citigroup slashed StoneCo Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/STNE#NASDAQ">STNE</a>) price target from $19 to $9. Citigroup analyst Gustavo Schroden downgraded the stock from Buy to Neutral. StoneCo shares closed at $8.74 on Wednesday.  <a href="https://www.benzinga.com/quote/STNE/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>JP Morgan raised the price target for Lululemon Athletica Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LULU#NASDAQ">LULU</a>) from $428 to $437. JP Morgan analyst Matthew Boss maintained an Overweight rating. Lululemon shares settled at $376.66 on Wednesday. <a href="https://www.benzinga.com/quote/LULU/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Northland Capital Markets raised Vitesse Energy, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VTS#NYSE">VTS</a>) price target from $28 to $31. Northland Capital Markets analyst Bobby Brooks maintained an Outperform rating. Vitesse Energy shares closed at $27.12 on Wednesday. <a href="https://www.benzinga.com/quote/VTS/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>JP Morgan raised The Goldman Sachs Group, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GS#NYSE">GS</a>) price target from $550 to $605. JP Morgan analyst Kian Abouhossein maintained an Overweight rating. Goldman Sachs shares closed at $605.92 on Wednesday. <a href="https://www.benzinga.com/quote/GS/analyst-ratings">See how other analysts view this stock</a>.</li>
</ul>
Read This Next: 
<ul>
<li><a href="https://www.benzinga.com/news/earnings/25/01/43026927/how-to-earn-500-a-month-from-j-b-hunt-transport-stock-ahead-of-q4-earnings">How To Earn $500 A Month From J.B. Hunt Transport Stock Ahead Of Q4 Earnings</a></li>
</ul>

CBRL

DXCM

LULU

STNE

Lululemon To Rally Around 16%? Here Are 10 Top Analyst Forecasts For Thursday

Canaccord Genuity analyst Joseph Vafi maintains Concentrix (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CNXC#NASDAQ">CNXC</a>) with a Buy and lowers the price target from $100 to $80.

Canaccord Genuity Maintains Buy on Concentrix, Lowers Price Target to $80

Press Releases

Concentrix Schedules Release of Third Quarter 2024 Financial Results and Webcast of Investor Conference Call

Concentrix Reports Third Quarter 2024 Results

General

Concentrix Introduces Intelligent Experience Technology Product Suite with Launch of iX Hello™

Concentrix to share new insights on AI and intelligent experiences at Web Summit 2024

Concentrix Schedules Release of Fourth Quarter and Full Year Fiscal 2024 Financial Results and Webcast of Investor Conference Call

Concentrix Reports Fourth Quarter and Fiscal Year 2024 Results

Concentrix Positioned as Highest Leader in Everest Group's B2B Sales Services PEAK Matrix® Assessment 2024

Introducing iX Hello™2.0: Smarter multi-modal customer facing assistants that are easy to create, customize and integrate across the enterprise

Concentrix Schedules Release of First Quarter 2025 Financial Results and Webcast of Investor Conference Call

Comments

Concentrix

Noticias

Últimas noticias sobre Concentrix (NASDAQ:CNXC) Bolsa

La gente también mira

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL